Oragenics Inc (OGEN): He’s back

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Oragenics Inc (OGEN)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	0
Posts	11812
Boards Moderated	0
Alias Born	08/30/2005

Re: None

Monday, 12/03/2018 6:06:38 PM

Monday, December 03, 2018 6:06:38 PM

He’s back

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent OGEN News

Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 12:14:33 PM
Oragenics Partners with Avance Clinical for Phase II Concussion Trial in Australia • GlobeNewswire Inc. • 05/07/2024 12:00:00 PM
Oragenics, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards • Business Wire • 04/19/2024 09:50:00 PM
Oragenics, Inc. Files 10K and Provides Company Update • Business Wire • 04/01/2024 01:05:00 PM
Oragenics Appoints James Kelly MD, Chief Medical Officer, to Lead Phase II Clinical Trials for Treating Concussion • Business Wire • 03/18/2024 11:00:00 AM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 03/06/2024 09:24:29 PM
Oragenics, Inc. Prepares Drug for Phase II Clinical Trials to Treat Concussion • Business Wire • 03/05/2024 12:45:00 PM
Oragenics Announces Closing of Public Offering • Business Wire • 03/01/2024 09:04:00 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/29/2024 09:41:14 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 02:03:04 PM
Oragenics Announces Pricing of Public Offering • Business Wire • 02/28/2024 02:25:00 AM
Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses • Edgar (US Regulatory) • 02/27/2024 10:09:12 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/27/2024 10:04:34 PM
Oragenics Announces Proposed Public Offering • Business Wire • 02/27/2024 09:33:00 PM
Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 02/13/2024 01:06:23 AM
Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 09:45:18 PM
Oragenics, Inc. Announces Leadership Transition • Business Wire • 02/12/2024 09:41:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2024 01:00:18 PM
Oragenics, Inc. Announces Expiration of Its Investment Banking Engagement Agreement • Business Wire • 02/07/2024 01:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 01:00:23 PM
Oragenics, Inc. Preparing for Phase II Clinical Trials to Treat Concussion • Business Wire • 02/05/2024 01:00:00 PM
Oragenics Announces Termination of At-The-Market Offering Program • Business Wire • 01/23/2024 10:34:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 10:18:59 PM
Form 5 - Annual statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/22/2024 10:30:15 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2024 02:10:51 PM

More OGEN News

InvestorsHub NewsWire

Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM

VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow